Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...
In the real world, the use of semaglutide (Wegovy) and tirzepatide (Zepbound) produce far less weight loss than in the randomized clinical trials, largely because people discontinue using them early ...
Real-world data suggests weight loss durability post-GLP-1 drug discontinuation Study suggests weight regain may be less common than clinical trial extensions indicate Behavioral changes may aid ...
Share on Pinterest To lose weight with GLP-1 drugs and keep it off, it’s important to adopt lifestyle habits like a balanced diet and regular exercise. Steve Christo – Corbis/Getty Images Researchers ...
Injectable GLP-1 receptor agonists show reduced effectiveness in real-world settings due to early discontinuation and low maintenance dosing. Patients maintaining treatment lost more weight, with high ...
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found. Reading time 4 minutes When it comes to weight loss, surgery still reigns ...
Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The trial results are among the pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results